CymaBay Therapeutics Inc. (CBAY) is destined for greater heights as its last quarter sales were 0 K

CymaBay Therapeutics Inc. (NASDAQ: CBAY) on January 24, 2023, started off the session at the price of $7.20, soaring 15.89% from the previous trading day. During the day, the shares moved up to $7.825 and dropped to $7.02 before settling in for the closing price of $6.61. Within the past 52 weeks, CBAY’s price has moved between $1.67 and $7.15.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


The company achieved an average annual earnings per share of -71.10%. With a float of $80.92 million, this company’s outstanding shares have now reached $87.80 million.

In an organization with 60 employees, it is important to assess its efficiency.

CymaBay Therapeutics Inc. (CBAY) Insider Updates

Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CymaBay Therapeutics Inc. is 0.39%, while institutional ownership is 76.30%. The most recent insider transaction that took place on Jun 06, was worth 100,037. In this transaction Chief Executive Officer of this company bought 51,301 shares at a rate of $1.95, taking the stock ownership to the 171,301 shares.

CymaBay Therapeutics Inc. (CBAY) Performance Highlights and Predictions

As on 6/29/2022, Multinational firm has announced its last quarter scores, in which it reported -$0.31 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.3) by -$0.01. This company achieved a return on equity of -65.30. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -71.10% per share during the next fiscal year.

CymaBay Therapeutics Inc. (NASDAQ: CBAY) Trading Performance Indicators

CymaBay Therapeutics Inc. (CBAY) is currently performing well based on its current performance indicators. A quick ratio of 12.20 was reported for the most recent quarter.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.25, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.11 in one year’s time.

Technical Analysis of CymaBay Therapeutics Inc. (CBAY)

Let’s dig in a bit further. During the last 5-days, its volume was 2.54 million. That was better than the volume of 1.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 77.81%. Additionally, its Average True Range was 0.45.

During the past 100 days, CymaBay Therapeutics Inc.’s (CBAY) raw stochastic average was set at 96.47%, which indicates a significant increase from 92.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.05% in the past 14 days, which was higher than the 63.60% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.81, while its 200-day Moving Average is $3.50. However, in the short run, CymaBay Therapeutics Inc.’s stock first resistance to watch stands at $7.98. Second resistance stands at $8.31. The third major resistance level sits at $8.79. If the price goes on to break the first support level at $7.18, it is likely to go to the next support level at $6.70. Assuming the price breaks the second support level, the third support level stands at $6.37.

CymaBay Therapeutics Inc. (NASDAQ: CBAY) Key Stats

Market capitalization of the company is 624.37 million based on 84,678K outstanding shares. Right now, sales total 0 K and income totals -90,000 K. The company made 0 K in profit during its latest quarter, and -24,505 K in sales during its previous quarter.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Do You Know Why Evolv Technologies (EVLV) Stock Surged Nearly 10% Today?

Today's charts show Evolv Technologies Holdings Inc. (Nasdaq: EVLV)...

Catalyst Biosciences Inc. (CBIO) Open at price of $0.2951: A Brand-New Opportunity for Investors

Catalyst Biosciences Inc. (NASDAQ: CBIO) open the trading on February 02, 2023, with great promise as it jumped 7.94% to $0.30. During the day,...

Wabash National Corporation (WNC) Moves 12.15% Higher: These Numbers are Too Good to be True

Witnessing the stock’s movement on the chart, on February 02, 2023, Wabash National Corporation (NYSE: WNC) set off with pace as it heaved 12.15%...

Vishay Intertechnology Inc. (VSH) is set for another landmark as it hit the volume of 1.58 million

Vishay Intertechnology Inc. (NYSE: VSH) established initial surge of 3.45% at $24.28, as the Stock market unbolted on February 02, 2023. During the day,...


Please enter your comment!
Please enter your name here